SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-031130
Filing Date
2017-05-09
Accepted
2017-05-09 16:02:35
Documents
47
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a17-8866_110q.htm 10-Q 930188
2 EX-31.1 a17-8866_1ex31d1.htm EX-31.1 14041
3 EX-31.2 a17-8866_1ex31d2.htm EX-31.2 13671
4 EX-32.1 a17-8866_1ex32d1.htm EX-32.1 7825
5 EX-32.2 a17-8866_1ex32d2.htm EX-32.2 7806
  Complete submission text file 0001104659-17-031130.txt   3999026

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT loxo-20170331.xml EX-101.INS 902833
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT loxo-20170331.xsd EX-101.SCH 30509
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT loxo-20170331_cal.xml EX-101.CAL 28470
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT loxo-20170331_def.xml EX-101.DEF 106340
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT loxo-20170331_lab.xml EX-101.LAB 299365
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT loxo-20170331_pre.xml EX-101.PRE 197493
Mailing Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36562 | Film No.: 17826318
SIC: 2834 Pharmaceutical Preparations